基于CT的影像组学用于鉴别肾脏肿瘤:一项系统综述
该研究系统检索了PubMed、Scopus和Web of Science,纳入13项关于CT影像组学对肾脏肿瘤分级及亚型鉴别的研究,并以影像组学质量评分(RQS)评估研究质量。结果显示,CT影像组学在区分低级别与高级别透明细胞肾细胞癌(AUC=0.82-0.978)、低级别与高级别嫌色细胞癌(AUC=0.84)以及鉴别多种肾脏肿瘤类型(AUC 0.82-0.96)方面表现良好,纹理特征是最常用的鉴别特征。
要点
- CT影像组学对低级别与高级别透明细胞肾细胞癌的鉴别表现良好,AUC为0.82-0.978。
- CT影像组学鉴别透明细胞肾细胞癌、乏脂肪血管平滑肌脂肪瘤、乳头状肾细胞癌、嫌色细胞癌及肾嗜酸细胞瘤的AUC为0.82-0.96。
- 纹理特征是研究所用最主要的肿瘤鉴别影像组学特征,Fuhrman是最常用的病理分级系统。
核心结论
- 肾脏肿瘤可通过基于CT的影像组学进行病理分类,且表现良好。
- 用于肿瘤鉴别的主要影像组学特征是纹理特征。
- Fuhrman是所综述研究中最常用的病理分级系统。
- 肾脏肿瘤分级研究应扩展至透明细胞肾细胞癌和嫌色细胞癌之外。
研究设计与样本
- 系统综述,遵循PRISMA清单,检索PubMed、Scopus和Web of Science数据库。
- 共纳入13项研究,采用影像组学质量评分(RQS)评估每项研究质量。
- 主要结局为预测病理分级及鉴别肾脏肿瘤类型,以受试者工作特征曲线或精确率-召回率曲线的曲线下面积(AUC)衡量。
- 提取的预测病理分级或肿瘤亚型的特征包括形状、强度、纹理和小波(一种高阶特征)。
诊断标准与关键数值
- 四项研究区分低级别与高级别透明细胞肾细胞癌,表现良好,AUC=0.82-0.978。
- 一项研究区分低级别与高级别嫌色细胞癌,AUC=0.84。
- 八项研究用影像组学鉴别透明细胞肾细胞癌、乏脂肪血管平滑肌脂肪瘤、乳头状肾细胞癌、嫌色细胞癌和肾嗜酸细胞瘤等肿瘤类型,表现水平高,AUC 0.82-0.96。
临床应用与阅片要点
- 作者认为,肾脏肿瘤分级研究应扩展至透明细胞肾细胞癌和嫌色细胞癌之外。
- 作者认为,在临床环境中开展、跨多家机构的更大样本前瞻性研究将有助于临床转化至放射科医师工作站。
局限性
- 原文指出肾脏肿瘤分级研究应扩展至透明细胞肾细胞癌和嫌色细胞癌之外。
- 原文指出需要更大样本的前瞻性研究、在临床环境中开展并跨多家机构进行,以帮助临床转化至放射科医师工作站。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Differentiating renal tumours into grades and tumour subtype from medical imaging is important for patient management; however, there is an element of subjectivity when performed qualitatively. Quantitative analysis such as radiomics may provide a more objective approach. The purpose of this article is to systematically review the literature on computed tomography (CT) radiomics for grading and differentiating renal tumour subtypes. An educational perspective will also be provided.
METHODS: The Preferred Reporting Items for Systematic Reviews and Meta-Analyses checklist was followed. PubMed, Scopus and Web of Science were searched for relevant articles. The quality of each study was assessed using the Radiomic Quality Score (RQS).
RESULTS: 13 studies were found. The main outcomes were prediction of pathological grade and differentiating between renal tumour types, measured as area under the curve (AUC) for either the receiver operator curve or precision recall curve. Features extracted to predict pathological grade or tumour subtype included shape, intensity, texture and wavelet (a type of higher order feature). Four studies differentiated between low-grade and high-grade clear cell renal cell cancer (RCC) with good performance (AUC = 0.82-0.978). One other study differentiated low- and high-grade chromophobe with AUC = 0.84. Finally, eight studies used radiomics to differentiate between tumour types such as clear cell RCC, fat-poor angiomyolipoma, papillary RCC, chromophobe RCC and renal oncocytoma with high levels of performance (AUC 0.82-0.96).
CONCLUSION: Renal tumours can be pathologically classified using CT-based radiomics with good performance. The main radiomic feature used for tumour differentiation was texture. Fuhrman was the most common pathologic grading system used in the reviewed studies. Renal tumour grading studies should be extended beyond clear cell RCC and chromophobe RCC. Further research with larger prospective studies, performed in the clinical setting, across multiple institutions would help with clinical translation to the radiologist's workstation.
引用
- Bhandari A, Ibrahim M, Sharma C, et al. CT-based radiomics for differentiating renal tumours: a systematic review. Abdom Radiol (NY). 2020. PMID: 33136182. doi:10.1007/s00261-020-02832-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。